Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$372,210
+$9,429 QoQ
Shares Held
2,375
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,019
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
This page
|
2,375 | $372,210 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $372,210 | 2,375 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $362,781 | 2,375 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $327,441 | 2,375 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $304,570 | 2,375 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $287,398 | 2,375 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $264,765 | 2,375 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $231,111 | 2,375 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $273,172 | 2,375 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $252,842 | 2,375 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $229,733 | 2,375 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $239,803 | 2,375 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $404,893 | 3,975 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $401,117 | 3,975 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $556,600 | 6,050 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $548,856 | 6,050 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $459,860 | 6,050 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $511,406 | 6,050 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $530,887 | 6,050 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $529,193 | 6,050 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $494,769 | 6,050 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $552,002 | 6,050 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $517,154 | 6,050 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $571,301 | 6,050 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $680,462 | 7,825 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $753,307 | 8,625 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $711,131 | 8,625 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||